XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 25, 2022
Jun. 26, 2021
OPERATING ACTIVITIES    
Net income $ 237,394 $ 169,534
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 28,045 24,244
Non-cash interest charges 224 224
Provisions for losses on trade and other accounts receivable 6,359 1,393
Gains on sales/disposals of operating property (1,213) (766)
Deferred income taxes, net 5,999 6,240
Stock-based compensation 5,810 10,893
Changes in operating assets and liabilities:    
Increase in trade and other accounts receivable (82,233) (55,236)
Increase in other assets (42,742) (24,704)
Increase in accounts payable 66,404 101,206
(Decrease) increase in other liabilities (25,265) 7,882
Increase (decrease) in insurance claims 10,869 (103,734)
NET CASH PROVIDED BY OPERATING ACTIVITIES 209,651 137,176
INVESTING ACTIVITIES    
Sales and maturities of investments 21,918 17,242
Purchases of investments (23,883) (68,366)
Purchases of operating property (7,467) (9,000)
Proceeds from sales of operating property 2,358 1,438
Purchase of non-marketable securities (4,999)  
NET CASH USED BY INVESTING ACTIVITIES (12,073) (58,686)
FINANCING ACTIVITIES    
Decrease in cash overdraft (2,875) (4,194)
Dividends paid (93,968) (92,905)
Proceeds from exercises of stock options 56 77
Taxes paid in lieu of shares issued related to stock-based compensation plans (10,269) (2,341)
Purchases of common stock (212,632) (23,837)
Principal payments on finance lease obligations (19,051) (19,143)
Payment of deferred consideration   (168)
NET CASH USED BY FINANCING ACTIVITIES (338,739) (142,511)
Effect of exchange rate changes on cash and cash equivalents (190) 1,071
Decrease in cash, cash equivalents and restricted cash (141,351) (62,950)
Cash, cash equivalents and restricted cash at beginning of period 219,571 249,354
Cash, cash equivalents and restricted cash at end of period $ 78,220 $ 186,404